WILLEMSTAD – A union collaborator has submitted a series of critical questions to Curaçao’s Minister of Finance, Javier Silvania, raising concerns about the recent acquisition of two new ambulances by Fundashon Kuido Ambulans Kòrsou (FKAK). The message, sent via a mobile app, highlights issues related to procurement transparency, technical suitability, and operational readiness.
The union collaborator questioned why the ambulances were purchased without a public tender process, as is customary under corporate governance standards. The message noted that in the past, governments have benchmarked both the local and U.S. markets before making major healthcare purchases—especially when large public funds are involved.
“Why wasn’t a public procurement process held, as has always happened under past governments?” the message asked. “Why wasn’t the local or U.S. market benchmarked, considering the significant amount of money being spent?”
The note also questioned whether FKAK consulted its own staff before selecting the vehicles, particularly to ensure that they are suited for Curaçao’s road infrastructure and operational conditions. Concerns were raised about the height of the ambulances, the safety of both patients and medical personnel, and whether the stretchers are of a hydraulic system like the previously used Stryker brand, which helps reduce physical strain on workers.
Another issue raised was whether the ambulances were chosen with sufficient technical input from experts, particularly in relation to vehicle maneuverability, shock absorption for trauma patients, and compatibility with Curaçao’s terrain and infrastructure. The collaborator questioned whether the new units can even fit inside the garage of the Curaçao Medical Center (CMC).
The collaborator further questioned why FKAK moved away from its standard use of Ford-brand vehicles, especially given the advantages of uniformity in maintenance and spare parts. In light of FKAK Director Mr. Keli’s previous statement that smaller ambulance models were no longer available in the U.S. post-COVID, the message pressed:
“Why not look at other brands like Chevrolet or source ambulances from the Netherlands? Why weren’t Dutch or American experts consulted?”
Lastly, the collaborator asked whether the new ambulances came fully equipped with all necessary medical instruments, or whether additional investments will still be needed to make them operational.
Minister Silvania has not yet issued a public response, but the message underscores growing concern among healthcare workers about the transparency and strategic planning behind key public health decisions.
